One of the reasons that physicians may not be associating adverse events, like strokes, seizures, neurological issues, blood clots, etc., is that Pfizer ran almost no bloodwork during their studies. During their single phase I trial of 30 subjects they only did basic hematology and chemistry, showing transient decreases in lymphocytes. As per Good Laboratory Practices, Phase 1-3, pre and post drug bloodwork is critical and encompasses hematology, chemistry, inflammatory biomarkers, pharmacodynamics/pharmacokinetics, specialty markers like D-dimer, etc. This was not done. In their single Phase 2, which was simply the first 360 subjects enrolled, the remaining 39,640 (roughly) were considered as Phase 3, there was no blood work, other than immunogenicity, at all. How then can Pfizer or any physician know if an adverse effect is caused by the vaccine? We have no data on how the liver, kidney, vascular system, etc., is affected. Do pre and post D-dimer on your ...